{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:45:17Z","timestamp":1789764317900,"version":"4.0.1"},"reference-count":27,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2024,9,10]]},"abstract":"<jats:p>Background: Juvenile-onset Huntington\u2019s disease (JHD) represents 1\u20135% of Huntington\u2019s disease (HD) patients, with onset before the age of 21. Pediatric HD (PHD) relates to a proportion of JHD patients that is still under 18 years of age. So far, both populations have been excluded from interventional trials. Objective: Describe the prevalence and incidence of JHD and PHD in the Netherlands and explore their ability to participate in interventional trials. Methods: The prevalence and incidence of PHD and JHD patients in the Netherlands were analyzed. In addition, we explored proportions of JHD patients diagnosed at pediatric versus adult age, their diagnostic delay, and functional and modelled (CAP100) disease stage in JHD and adult-onset HD patients at diagnosis. Results: The prevalence of JHD and PHD relative to the total manifest HD population in January 2024 was between 0.84\u20131.25% and 0.09\u20130.14% respectively. The mean incidence of JHD patients being diagnosed was between 0.85\u20131.28 per 1000 patient years and of PHD 0.14 per 1.000.000 under-aged person years. 55% of JHD cases received a clinical diagnosis on adult age. At diagnosis, the majority of JHD patients was functionally compromised and adolescent-onset JHD patients were significantly less independent compared to adult-onset HD patients. Conclusions: In the Netherlands, the epidemiology of JHD and PHD is lower than previously suggested. More than half of JHD cases are not eligible for trials in the PHD population. Furthermore, higher functional dependency in JHD patients influences their ability to participate in trials. Lastly, certain UHDRS functional assessments and the CAP100 score do not seem appropriate for this particular group.<\/jats:p>","DOI":"10.3233\/jhd-240034","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T11:14:13Z","timestamp":1722942853000},"page":"357-368","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of Juvenile-Onset and Pediatric Huntington\u2019s Disease and Their Availability and Ability to Participate in Trials: A Dutch Population and Enroll-HD Observational Study"],"prefix":"10.1177","volume":"13","author":[{"given":"Hannah S.","family":"Bakels","sequence":"first","affiliation":[{"name":"Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Feleus","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands"},{"name":"Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Rodr\u00edguez-Girondo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Losekoot","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia K.","family":"Bijlsma","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund A.C.","family":"Roos","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne T.","family":"de Bot","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-240034_ref1","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(18)30294-1","article-title":"Biological and clinical manifestations of juvenile Huntington\u2019s disease: a retrospective analysis","volume":"17","author":"Fusilli","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.3233\/JHD-240034_ref2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mds.28823","article-title":"Juvenile-onset Huntington disease pathophysiology and neurodevelopment: a review","volume":"37","author":"Bakels","year":"2022","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-240034_ref3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/brainsci10090575","article-title":"The association between CAG repeat length and age of onset of juvenile-onset Huntington\u2019s disease","volume":"10","author":"Schultz","year":"2020","journal-title":"Brain Sci"},{"key":"10.3233\/JHD-240034_ref4","first-page":"2009","volume-title":"Juvenile Huntington\u2019s Disease and Other Trinucleotide Repeat Disorders","author":"Quarrell"},{"key":"10.3233\/JHD-240034_ref5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mad.2005.09.012","article-title":"Juvenile Huntington\u2019sdisease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?","volume":"127","author":"Squitieri","year":"2006","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JHD-240034_ref6","first-page":"1202","article-title":"The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size","volume":"60","author":"Brinkman","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JHD-240034_ref7","doi-asserted-by":"crossref","first-page":"e4f8606b742ef3","DOI":"10.1371\/4f8606b742ef3","article-title":"The prevalence of juvenile Huntington\u2019s disease: a review of the literature and meta-analysis","volume":"4","author":"Quarrell","year":"2012","journal-title":"PLoS Curr"},{"key":"10.3233\/JHD-240034_ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2021.05.012","article-title":"Data from ENROLL-HD: Is the prevalence of juvenile and pediatric Huntington\u2019s disease overestimated?","volume":"88","author":"Achenbach","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JHD-240034_ref9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443738","article-title":"The prevalence of Huntington\u2019s disease","volume":"46","author":"Rawlins","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JHD-240034_ref10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2217\/nmt-2016-0008","article-title":"The global prevalence of Huntington\u2019s disease: a systematic review and discussion","volume":"6","author":"Baig","year":"2016","journal-title":"Neurodegener Dis Manag"},{"key":"10.3233\/JHD-240034_ref11","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/mds.29228","article-title":"Prevalence and incidence of Huntington\u2019s disease: an updated systematic review and meta-analysis","volume":"37","author":"Medina","year":"2022","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-240034_ref12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/mds.27640","article-title":"Defining pediatric huntington disease: Time to abandon the term juvenile Huntington disease?","volume":"34","author":"Quarrell","year":"2019","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-240034_ref13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2310\/7010.2006.00055","article-title":"Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature","volume":"21","author":"Gonzalez-Alegre","year":"2006","journal-title":"J Child Neurol"},{"key":"10.3233\/JHD-240034_ref14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.64.6.813","article-title":"Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients","volume":"64","author":"Ribai","year":"2007","journal-title":"Arch Neurol"},{"key":"10.3233\/JHD-240034_ref15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/brainsci10030155","article-title":"Diagnosing juvenile Huntington\u2019s disease: an explorative study among caregivers of affected children","volume":"10","author":"Oosterloo","year":"2020","journal-title":"Brain Sci"},{"key":"10.3233\/JHD-240034_ref16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JHD-210475","article-title":"Standardizing the CAP score in Huntington\u2019s disease by predicting age-at-onset","volume":"11","author":"Warner","year":"2022","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240034_ref17","doi-asserted-by":"crossref","first-page":"667420","DOI":"10.3389\/fneur.2021.667420","article-title":"Enroll-HD: an integrated clinical research platform and worldwide observational study for Huntington\u2019s disease","volume":"12","author":"Sathe","year":"2021","journal-title":"Front Neurol"},{"key":"10.3233\/JHD-240034_ref18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JHD-180339","article-title":"Clinical presentation and features of juvenile-onset Huntington\u2019s disease: a systematic review","volume":"8","author":"Cronin","year":"2019","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240034_ref19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","article-title":"A biological classification of Huntington\u2019s disease: the Integrated Staging System","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.3233\/JHD-240034_ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.29.1.1","article-title":"Huntington disease: clinical care and evaluation","volume":"29","author":"Shoulson","year":"1979","journal-title":"Neurology"},{"key":"10.3233\/JHD-240034_ref21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.57.4.658","article-title":"Clinical markers of early disease in persons near onset of Huntington\u2019s disease","volume":"57","author":"Paulsen","year":"2001","journal-title":"Neurology"},{"key":"10.3233\/JHD-240034_ref22","first-page":"136","article-title":"Huntington Study Group","volume":"11","author":"Unified Huntington\u2019s Disease Rating Scale: reliability and consistency","year":"1996","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-240034_ref23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00005792-200207000-00001","article-title":"Predictability ofage at onset in Huntington disease in the Dutch population","volume":"81","author":"Maat-Kievit","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.3233\/JHD-240034_ref24","doi-asserted-by":"crossref","first-page":"106049","DOI":"10.1016\/j.parkreldis.2024.106049","article-title":"Huntington disease - Update on ongoing therapeutic developments and a look toward the future","volume":"122","author":"Sampaio","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JHD-240034_ref25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/JHD-180306","article-title":"Assessment of the performance of a modified motor scale as applied to juvenile onset Huntington\u2019s disease","volume":"8","author":"Horton","year":"2019","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240034_ref26","first-page":"181","volume-title":"Juvenile Huntington\u2019s Disease and Other Trinucleotide Repeat Disorders","author":"Brewer","year":"2009"},{"key":"10.3233\/JHD-240034_ref27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1212\/WNL.0b013e3181bd1121","article-title":"Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease","volume":"73","author":"Aziz","year":"2009","journal-title":"Neurology"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-240034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:56:28Z","timestamp":1777452988000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-240034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":27,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jhd-240034","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]}}}